U.S. Physical Therapy, Inc. reported strong second-quarter 2026 financial results, with revenue increasing 8.5% year-over-year, driven by its physical therapy operations. The company also provided full-year adjusted EBITDA guidance, which will be a key metric for investors assessing future performance.
U.S. Physical Therapy, Inc. announced its second-quarter 2026 financial results, showing an 8.5% year-over-year revenue increase to $214 million, primarily from its physical therapy segment. This positive revenue growth, coupled with the provision of full-year adjusted EBITDA guidance of $102 million to $106 million, offers investors a clear outlook on the company's performance. The strong patient visit numbers and a solid adjusted physical therapy gross margin suggest operational efficiency. This news is a short-term positive for USPH, indicating healthy business momentum and providing a benchmark for future expectations, offering an opportunity for traders to consider long positions based on the positive growth and guidance.